ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Cardiomyopathies: 2024 Wrap Up

Cardiology 2024 Year in Review

A. Masri

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Overview of Genetic Dilated Cardiomyopathy (DCM)

Precision Cardiovascular Care 2024: Transitioning Care from Phenotypes to Genotypes

Q. Bui

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

Top 5 Arrhythmias You Need to Know

Joel Gorfinkel

HFpEF in Women

Scripps Health

B. Borlaug

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Hypertrophic Cardiomyopathy: Diagnosis and Treatment

Scripps Health

R. C. Mohan

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

An Efficient Approach to Addressing Syncope in the Office

Dr. Vu Kiet Tran

V. Tran

SGLT2 Inhibition in 2024: Use in Heart Failure and Mechanism of Acti…

28th Annual Heart Failure 2024: An Update on Therapy

M. Packer

Hypertrophic Cardiomyopathy: the Past, the Present, and the Future

Canadian Collaborative Research Network

E. Braunwald

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

New Generation of Stents Are Needed for Renal Vein Stenting

Transformative Endovascular Decisions Conference

M. Razavi